EIGER BIOPHARMACEUTICALS INC - COM (EIGR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q2 2024

Type / Class
Equity / COM
Symbol
EIGR
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 21,300 $204,000 $0 $9.58 1
2024 Q1 0 $0 -$4,152,469 0
2023 Q4 18,539,609 $4,161,105 -$1,602,213 $0.22 40
2023 Q3 19,942,902 $6,082,053 -$496,460 $0.30 48
2023 Q2 20,788,000 $14,637,934 -$3,018,818 $0.70 64
2023 Q1 24,795,534 $22,238,768 -$457,336 $0.90 68
2022 Q4 25,108,996 $29,634,052 -$37,747,382 $1.18 79
2022 Q3 29,842,574 $224,711,367 +$6,075,966 $7.53 90
2022 Q2 29,772,658 $187,572,238 -$6,860,222 $6.30 88
2022 Q1 30,334,612 $251,773,789 +$56,530,073 $8.30 92
2021 Q4 23,916,751 $124,115,346 +$5,614,030 $5.19 83
2021 Q3 22,591,855 $150,982,700 -$3,864,265 $6.68 90
2021 Q2 23,041,884 $196,315,315 -$5,313,318 $8.52 87
2021 Q1 23,446,257 $207,480,996 -$2,259,521 $8.85 92
2020 Q4 23,584,953 $289,784,608 +$24,041,949 $12.29 91
2020 Q3 22,322,845 $181,745,165 +$22,382,957 $8.14 101
2020 Q2 19,479,257 $186,998,333 +$18,103,190 $9.60 94
2020 Q1 17,807,876 $121,090,658 -$3,683,592 $6.80 90
2019 Q4 18,451,685 $274,906,569 -$8,777,395 $14.90 91
2019 Q3 18,671,155 $191,359,943 -$21,780,003 $10.25 83
2019 Q2 20,708,295 $219,532,047 +$46,331,673 $10.60 77
2019 Q1 15,414,233 $215,433,314 -$1,881,513 $13.98 62
2018 Q4 15,571,016 $158,042,032 +$54,751,931 $10.16 65
2018 Q3 9,817,818 $117,841,400 -$696,042 $12.00 50
2018 Q2 9,865,297 $120,348,489 +$36,889,876 $12.20 48
2018 Q1 6,954,537 $68,503,621 -$6,760,931 $9.85 37
2017 Q4 7,254,866 $101,212,879 +$23,279,679 $13.95 39
2017 Q3 4,946,091 $54,401,693 +$270,550 $11.00 30
2017 Q2 5,010,694 $39,581,498 -$9,127,813 $7.90 37
2017 Q1 5,785,111 $66,237,115 -$810,925 $11.45 47
2016 Q4 6,042,727 $70,390,664 -$1,075,176 $11.65 49
2016 Q3 4,520,826 $60,530,502 +$16,896,058 $13.39 45
2016 Q2 3,242,523 $64,263,216 +$3,934,001 $19.82 42
2016 Q1 3,047,617 $51,110,000 +$24,210,000 $16.77 28